Nautilus Biotechnology, Inc. (NAUT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -13.1M | -12.38M | -11.03M | -13.35M | -13.94M | -14.31M | -13.11M | -15.46M | -16.27M | -13.9M | -11.74M | -13.55M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 6.01% | 13.52% | 15.85% | 13.63% | 14.32% | -2.94% | -11.71% | -14.08% | -29.88% | -33.95% | -22.72% | -0.15% |
| Net Income | -14.7M | -13.78M | -13.57M | -15.03M | -16.61M | -17.59M | -16.45M | -18.01M | -18.73M | -17.02M | -15.88M | -15.81M |
| Depreciation & Amortization | 1.48M | 1.59M | 1.62M | 1.63M | 1.63M | 1.55M | 1.61M | 1.6M | 1.59M | 1.59M | 1.48M | 1.42M |
| Stock-Based Compensation | 1.36M | 1.47M | 1.5M | 1.71M | 2.17M | 3.12M | 3.18M | 3.28M | 3.11M | 3.07M | 3.11M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -627.55K | 0 |
| Other Non-Cash Items | -68K | -134K | -306K | -439K | -541K | 216K | -723K | -702K | -751K | -619K | -449 | 2.4M |
| Working Capital Changes | -1.17M | -1.52M | -269K | -1.22M | -576K | -1.61M | -740K | -1.62M | -1.49M | -920K | 179K | -1.56M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 200K | 2K | -20K | 80K | -131K | -543K | 273K | -402K | 94K | 371K | 221K | -252K |
| Cash from Investing | 14.23M | 787K | 452K | 14.47M | 19.51M | 37.11M | -7.5M | 14.29M | 22.35M | -41.06M | 13.07M | -2.25M |
| Capital Expenditures | -510K | -244K | -418K | -396K | -219K | -254K | -709K | -512K | -647K | -413K | -874K | -463K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.95K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -11.13M | 0 | 0 | 0 | -760K | 0 | 0 | 0 | 0 | 13.95K | 0 |
| Cash from Financing | 1.1M | 101K | 0 | 95K | 18K | 440K | 140K | 319K | 245K | 253K | 16K | 98K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.1M | 101K | 0 | 95K | 18K | 440K | 140K | 319K | 245K | 253K | 16K | 98K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 2.24M | -11.49M | -10.58M | 1.22M | 5.59M | 23.24M | -20.48M | -844K | 6.33M | -54.71M | 1.35M | -16.37M |
| Free Cash Flow | -13.61M | -12.62M | -11.45M | -13.75M | -14.16M | -14.56M | -13.82M | -15.97M | -16.91M | -14.31M | -12.61M | -14.01M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 3.86% | 13.35% | 17.15% | 13.92% | 16.3% | -1.75% | -9.59% | -13.97% | -27.97% | -34.95% | -19.79% | 1.18% |
| FCF per Share | -0.11 | -0.10 | -0.09 | -0.11 | -0.11 | -0.12 | -0.11 | -0.13 | -0.14 | -0.11 | -0.10 | -0.11 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.90x | 0.81x | 0.89x | 0.84x | 0.81x | 0.80x | 0.86x | 0.87x | 0.82x | 0.74x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |